X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (640) 640
inhaled iloprost (434) 434
pulmonary hypertension (419) 419
index medicus (412) 412
hypertension, pulmonary - drug therapy (402) 402
inhaled nitric-oxide (332) 332
respiratory system (246) 246
cardiac & cardiovascular systems (245) 245
hypertension, pulmonary - physiopathology (245) 245
female (229) 229
male (223) 223
arterial-hypertension (207) 207
pulmonary arterial hypertension (204) 204
double-blind (199) 199
therapy (191) 191
prostacyclin (189) 189
sildenafil (189) 189
vasodilator agents - therapeutic use (159) 159
hypertension (155) 155
treatment outcome (149) 149
bosentan (144) 144
oral sildenafil (144) 144
adult (143) 143
iloprost (142) 142
middle aged (141) 141
antihypertensive agents - therapeutic use (139) 139
continuous intravenous epoprostenol (136) 136
administration, inhalation (132) 132
pharmacology & pharmacy (128) 128
survival (128) 128
sildenafil citrate (123) 123
care and treatment (119) 119
animals (116) 116
hypertension, pulmonary - etiology (116) 116
hypertension, pulmonary - diagnosis (114) 114
medicine, general & internal (110) 110
drug therapy, combination (107) 107
prostacyclin analog (107) 107
vasodilator agents - administration & dosage (106) 106
hypertension, pulmonary - therapy (105) 105
placebo-controlled trial (105) 105
pediatrics (99) 99
drug therapy (97) 97
epoprostenol (97) 97
calcium-channel blockers (91) 91
nitric oxide (89) 89
epoprostenol - therapeutic use (88) 88
endothelin receptor antagonists (87) 87
combination therapy (84) 84
piperazines - therapeutic use (83) 83
long-term treatment (80) 80
treprostinil (80) 80
iloprost - administration & dosage (77) 77
aged (76) 76
epoprostenol - analogs & derivatives (76) 76
surgery (75) 75
abridged index medicus (71) 71
antihypertensive agents - administration & dosage (71) 71
child (71) 71
critical care medicine (71) 71
hemodynamics (71) 71
pulmonary arteries (70) 70
bosentan therapy (69) 69
congenital heart-disease (67) 67
mortality (66) 66
aerosolized iloprost (64) 64
research (64) 64
controlled-trial (63) 63
phosphodiesterase inhibitors - therapeutic use (63) 63
epoprostenol - administration & dosage (62) 62
diagnosis (61) 61
medicine & public health (61) 61
familial primary pulmonary hypertension (60) 60
infant, newborn (60) 60
endothelin-receptor antagonist (56) 56
purines (56) 56
sulfones (56) 56
children (55) 55
disease (55) 55
risk factors (55) 55
transplantation (54) 54
prognosis (53) 53
respiratory-distress-syndrome (53) 53
randomized controlled-trial (52) 52
adolescent (51) 51
vasodilators (51) 51
hypertension, pulmonary - complications (50) 50
vascular resistance - drug effects (50) 50
iloprost - therapeutic use (49) 49
lung transplantation (49) 49
nitric-oxide (49) 49
prostaglandins - therapeutic use (49) 49
cardiology (48) 48
cardiovascular (48) 48
endothelin receptor antagonist (48) 48
hemodynamics - drug effects (48) 48
endothelin (47) 47
health aspects (47) 47
intravenous epoprostenol (46) 46
heart failure (45) 45
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (801) 801
German (41) 41
French (20) 20
Spanish (15) 15
Turkish (7) 7
Russian (5) 5
Portuguese (2) 2
Japanese (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Endodontics, ISSN 0099-2399, 2014, Volume 40, Issue 11, pp. 1784 - 1790
Journal Article
Journal Article
European Respiratory Journal, ISSN 0903-1936, 07/2009, Volume 34, Issue 1, pp. 132 - 137
Journal Article
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, ISSN 0277-0008, 09/2016, Volume 36, Issue 9, pp. e142 - e147
Journal Article
American Journal of Physiology - Lung Cellular and Molecular Physiology, ISSN 1040-0605, 10/2018, Volume 315, Issue 4, pp. L535 - L544
Cyclooxygenase-2 (COX-2/PTGS2) mediates hyperoxia-induced impairment of lung development in newborn animals and is increased in the lungs of human infants with... 
infant, newborn | Infant | Newborn | prostacyclin | lung development | oxidative stress | INHALED ILOPROST | PHYSIOLOGY | AIRWAY INFLAMMATION | PRETERM INFANTS | newborn | ALVEOLAR DEVELOPMENT | infant | PRIMARY PULMONARY-HYPERTENSION | NEONATAL-RATS | BRONCHOPULMONARY DYSPLASIA | TUMOR-NECROSIS-FACTOR | RESPIRATORY SYSTEM | PROSTACYCLIN ANALOG | ARTERIAL-HYPERTENSION
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2012, Volume 7, Issue 12, p. e52248
Journal Article
Chest, ISSN 0012-3692, 2013, Volume 144, Issue 1, pp. 55 - 62
Objective We hypothesized that nebulized iloprost would improve ventilation-perfusion matching in patients with pulmonary hypertension and ARDS as reflected by... 
Pulmonary/Respiratory | MULTICENTER CLINICAL-TRIAL | THERAPY | RESPIRATORY SYSTEM | DOUBLE-BLIND | AEROSOLIZED PROSTACYCLIN | ACUTE LUNG INJURY | VASCULAR-RESISTANCE | INHALED NITRIC-OXIDE | PROSTAGLANDIN E | TLC C-53 | RESPIRATORY-DISTRESS-SYNDROME | CRITICAL CARE MEDICINE | Respiratory Distress Syndrome, Adult - physiopathology | Iloprost - pharmacology | Vasodilator Agents - therapeutic use | Humans | Middle Aged | Hypertension, Pulmonary - physiopathology | Male | Hemodynamics - physiology | Dose-Response Relationship, Drug | Respiratory Mechanics - drug effects | Pulmonary Gas Exchange - drug effects | Adult | Female | Hypertension, Pulmonary - drug therapy | Respiratory Mechanics - physiology | Iloprost - administration & dosage | Vasodilator Agents - pharmacology | Comorbidity | Administration, Inhalation | Treatment Outcome | Hypertension, Pulmonary - epidemiology | Respiratory Distress Syndrome, Adult - drug therapy | Pulmonary Gas Exchange - physiology | Iloprost - therapeutic use | Aged | Hemodynamics - drug effects | Respiratory Distress Syndrome, Adult - epidemiology | Vasodilator Agents - administration & dosage | Acute respiratory distress syndrome | Iloprost | Care and treatment | Patient outcomes | Dosage and administration | Research | Hemodynamics | Pulmonary hypertension | Pulmonary gas exchange
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2010, Volume 104, Issue 5, pp. 731 - 740
Journal Article
Canadian Journal of Anesthesia/Journal canadien d'anesthésie, ISSN 0832-610X, 8/2019, Volume 66, Issue 8, pp. 907 - 920
Perioperative right ventricular (RV) failure due to pressure overload from pulmonary hypertension (PH) worsens postoperative outcomes after cardiac surgery.... 
Pediatrics | Pain Medicine | Pneumology/Respiratory System | Medicine & Public Health | Intensive / Critical Care Medicine | Anesthesiology | Cardiology | RIGHT-VENTRICULAR FAILURE | PULMONARY-HYPERTENSION | CONTRACTILITY | CIRCULATION | EPOPROSTENOL | SURGERY PATIENTS | PROSTACYCLIN | HEART-FAILURE | ANESTHESIOLOGY | CARDIOPULMONARY BYPASS | INHALED NITRIC-OXIDE
Journal Article
by Li, JH and Zhang, HD and Wang, ZZ and Lu, QQ and Li, D and Lian, TY and Lv, ZC and Jiang, X and Wu, Y and Ye, J and Zhao, SH and Yang, ZW
FRONTIERS IN PHARMACOLOGY, ISSN 1663-9812, 01/2019, Volume 9, p. 1550
Background: Right ventricle (RV) function is among the most important prognostic factors for pulmonary arterial hypertension (PAH) patients. Inhaled iloprost,... 
INHALED ILOPROST | iloprost | pulmonary artery hypertension | ANALOG | PROSTACYCLIN | HEART | THERAPY | right ventricle | PROSTAGLANDINS | ENHANCEMENT | PHARMACOLOGY & PHARMACY | pulmonary vascular resistance | cardiac magnetic resonance | Usage | Care and treatment | Iloprost | Prognosis | Magnetic resonance imaging | Dosage and administration | Pulmonary hypertension
Journal Article
Journal Article